TScan Therapeutics, Inc. (TCRX) Tops Q4 EPS by 9c Mar 4, 2026 04:07PM
BTIG Reiterates Neutral Rating on Tscan Therapeutics Inc (TCRX) Dec 9, 2025 06:34AM
Morgan Stanley Downgrades Tscan Therapeutics Inc (TCRX) to Equalweight Nov 13, 2025 05:19PM
TScan Therapeutics, Inc. (TCRX) Tops Q3 EPS by 6c Nov 12, 2025 04:36PM
BTIG Downgrades Tscan Therapeutics Inc (TCRX) to Neutral Nov 4, 2025 06:03AM


Nov 3, 2025 06:30AM TScan reaches FDA agreement on pivotal study design for TSC-101
Aug 12, 2025 09:45AM TScan Therapeutics, Inc. (TCRX) Tops Q2 EPS by 5c
May 7, 2025 07:20AM Tscan Therapeutics Inc (TCRX) PT Lowered to $10 at H.C. Wainwright
May 6, 2025 04:33PM TScan Therapeutics, Inc. (TCRX) Tops Q1 EPS by 54c
Mar 6, 2025 07:27AM H.C. Wainwright Reiterates Buy Rating on Tscan Therapeutics Inc (TCRX)
Mar 5, 2025 04:28PM TScan Therapeutics, Inc (TCRX) Files $300M Mixed Shelf
Mar 5, 2025 04:19PM TScan Therapeutics, Inc. (TCRX) Misses Q4 EPS by 1c
Dec 26, 2024 07:00AM TScan Therapeutics, Inc (TCRX) Announces 7.5M Share Offering at $4/sh
Nov 12, 2024 05:03PM TScan Therapeutics, Inc. (TCRX) Tops Q3 EPS by 6c
Aug 12, 2024 08:50AM TScan Therapeutics, Inc. (TCRX) Reports In-Line Q2 EPS
Jun 14, 2024 07:01AM TScan Therapeutics (TCRX) Announces Updates to its Board of Directors